Background Despite the proliferation of new psychoactive substances (NPS) in recent years, there are many gaps in our understanding of the phenomena. Current methodologies still fail to provide timely and scientifically reliable knowledge between controlled trials and online data reports that lack analytical confirmation of the reported substances. This study tests a new online, collaborative, observational methodology for tracking the emergence of NPS. It involves conducting laboratory analysis of community-submitted NPS samples using a naturalistic approach. Methods Participants were recruited from online communities of people who claim to use NPS. They were asked to send and report on the substances they would have taken independently of the study participation. They received free drug-checking services for the samples sent during the data collection. Participants were also asked to complete multiple online questionnaires to provide information about the analysed NPS samples. Comprehensive literature reviews of the analysed samples were conducted to assess the importance of the results. Results Participants sent 136 sample submission questionnaires. Ninety-two were followed by the laboratory analysis of a submitted NPS sample. Only 54 of those analysed NPS samples completed all the study protocols. Forty different NPS were identified in the laboratory analysis. Of those, 13 substances had no previous reports in the scientific literature as new psychoactive substances. Another 12 substances had no available peer-reviewed data regarding their subjective effects. Only one opioid and no synthetic cannabinoids were detected. Conclusions The confirmed identification of 13 previously unreported NPS demonstrates the capacity of the current methodology to identify potentially emerging NPS. Despite the vast diversity of substances submitted, the most common NPS types (e.g., cannabinoids and opioids) were not found. Altogether, these results warrant further research to consolidate the favourable impact of monitoring the NPS market using this innovative methodology.
Introducción: La 3-metilmetcatinona (3-MMC) es una catinona sintética perteneciente al grupo de nuevas sustancias psicoactivas (NPS). Es un isómero estructural de la mefedrona, siendo una alternativa a la misma en contexto de chemsex (1). El estudio de las NPS está limitado por la velocidad en que aparecen y desaparecen del mercado estas sustancias y por el difícil acceso a los usuarios de las mismas. La mayor parte de los datos actuales proceden de casos de intoxicación o cuestionarios online y la realización de ensayos clínicos aleatorizados es demasiado costosa y lenta. Nuevos métodos de estudio son necesarios en un momento en que cada vez las NPS ganan más relevancia (2). Objetivos: Describir el contexto de consumo y los efectos subjetivos de 3-MMC en una muestra de usuarios utilizando una metodología nueva, rápida y económica, basada en Internet. Métodos: Se ha realizado un estudio longitudinal y observacional, reclutando usuarios de NPS y realizando un seguimiento durante 14 meses, permitiéndoles enviar muestras de NPS para la confirmación analítica del resultado esperado. A continuación, seleccionamos los resultados relacionados con el consumo de 3-MMC. Resultados: De los 17 participantes que completaron el estudio, dos de ellos usaron 3-MMC en 6 ocasiones distintas. Ambos eran varones de entre 20-40 años y con estudios superiores. Ninguna de las dos muestras estaba adulterada. La vía de administración en uno de ellos fue oral y en el otro endovenosa, rectal y esnifada. En el segundo caso se consumió en contexto de chemsex. El rango de dosis fue entre 60-300 mg dependiendo de vía de administración. Ambos usuarios describieron un efecto estimulante similar a anfetamina o cocaína con características empatógenas del MDMA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.